U
Urovant Sciences, Inc.
UROVHealth Care· Boston, Massachusetts, United States
LAYOFFS TRACKED
2
LAST EVENT
Jul 24, 2023
MARKET CAP
—
EMPLOYEES
120
Urovant Sciences, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for urological conditions, including overactive bladder and other lower urinary tract disorders. The company's lead product is GEMTESA (vibegron) for the treatment of overactive bladder in adults.
Layoff history
EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS
22
1
Q2 '23Q1 '24Q1 '25Q1 '26Q3 '26
Layoff timeline
2 EVENTSStories from here
No one has shared a story from Urovant Sciences yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Urovant Sciences
We'll email you the moment a new layoff is reported here.